位置:首页 > 蛋白库 > LGI4_HUMAN
LGI4_HUMAN
ID   LGI4_HUMAN              Reviewed;         537 AA.
AC   Q8N135; B2RN53; B9EGS7; Q5M8T1;
DT   03-JUL-2003, integrated into UniProtKB/Swiss-Prot.
DT   01-OCT-2002, sequence version 1.
DT   03-AUG-2022, entry version 158.
DE   RecName: Full=Leucine-rich repeat LGI family member 4;
DE   AltName: Full=LGI1-like protein 3;
DE   AltName: Full=Leucine-rich glioma-inactivated protein 4;
DE   Flags: Precursor;
GN   Name=LGI4; Synonyms=LGIL3; ORFNames=UNQ6515/PRO21485;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), AND TISSUE SPECIFICITY.
RX   PubMed=12023020; DOI=10.1016/s0014-5793(02)02713-8;
RA   Gu W., Wevers A., Schroder H., Grzeschik K.H., Derst C., Brodtkorb E.,
RA   de Vos R., Steinlein O.K.;
RT   "The LGI1 gene involved in lateral temporal lobe epilepsy belongs to a new
RT   subfamily of leucine-rich repeat proteins.";
RL   FEBS Lett. 519:71-76(2002).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12095917; DOI=10.1093/hmg/11.15.1757;
RA   Scheel H., Tomiuk S., Hofmann K.;
RT   "A common protein interaction domain links two recently identified epilepsy
RT   genes.";
RL   Hum. Mol. Genet. 11:1757-1762(2002).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1).
RX   PubMed=12217514; DOI=10.1016/s0968-0004(02)02163-1;
RA   Staub E., Perez-Tur J., Siebert R., Nobile C., Moschonas N.K., Deloukas P.,
RA   Hinzmann B.;
RT   "The novel EPTP repeat defines a superfamily of proteins implicated in
RT   epileptic disorders.";
RL   Trends Biochem. Sci. 27:441-444(2002).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=12975309; DOI=10.1101/gr.1293003;
RA   Clark H.F., Gurney A.L., Abaya E., Baker K., Baldwin D.T., Brush J.,
RA   Chen J., Chow B., Chui C., Crowley C., Currell B., Deuel B., Dowd P.,
RA   Eaton D., Foster J.S., Grimaldi C., Gu Q., Hass P.E., Heldens S., Huang A.,
RA   Kim H.S., Klimowski L., Jin Y., Johnson S., Lee J., Lewis L., Liao D.,
RA   Mark M.R., Robbie E., Sanchez C., Schoenfeld J., Seshagiri S., Simmons L.,
RA   Singh J., Smith V., Stinson J., Vagts A., Vandlen R.L., Watanabe C.,
RA   Wieand D., Woods K., Xie M.-H., Yansura D.G., Yi S., Yu G., Yuan J.,
RA   Zhang M., Zhang Z., Goddard A.D., Wood W.I., Godowski P.J., Gray A.M.;
RT   "The secreted protein discovery initiative (SPDI), a large-scale effort to
RT   identify novel human secreted and transmembrane proteins: a bioinformatics
RT   assessment.";
RL   Genome Res. 13:2265-2270(2003).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2).
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [6]
RP   SUBCELLULAR LOCATION, INVOLVEMENT IN AMC1, AND VARIANTS AMC1 PRO-258;
RP   288-TRP--ALA-537 DEL AND ASP-434.
RX   PubMed=28318499; DOI=10.1016/j.ajhg.2017.02.006;
RA   Xue S., Maluenda J., Marguet F., Shboul M., Quevarec L., Bonnard C.,
RA   Ng A.Y., Tohari S., Tan T.T., Kong M.K., Monaghan K.G., Cho M.T.,
RA   Siskind C.E., Sampson J.B., Rocha C.T., Alkazaleh F., Gonzales M.,
RA   Rigonnot L., Whalen S., Gut M., Gut I., Bucourt M., Venkatesh B.,
RA   Laquerriere A., Reversade B., Melki J.;
RT   "Loss-of-function mutations in LGI4, a secreted ligand involved in schwann
RT   cell myelination, are responsible for arthrogryposis multiplex congenita.";
RL   Am. J. Hum. Genet. 100:659-665(2017).
CC   -!- FUNCTION: Component of Schwann cell signaling pathway(s) that controls
CC       axon segregation and myelin formation (By similarity).
CC       {ECO:0000250|UniProtKB:Q8K1S1}.
CC   -!- SUBUNIT: Can bind to ADAM11, ADAM22 and ADAM23. {ECO:0000250}.
CC   -!- SUBCELLULAR LOCATION: Secreted {ECO:0000305}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q8N135-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q8N135-2; Sequence=VSP_009230, VSP_009231;
CC   -!- TISSUE SPECIFICITY: Widely expressed, with highest expression in brain.
CC       {ECO:0000269|PubMed:12023020}.
CC   -!- DISEASE: Arthrogryposis multiplex congenita 1, neurogenic, with myelin
CC       defect (AMC1) [MIM:617468]: A form of arthrogryposis multiplex
CC       congenita, a developmental condition characterized by multiple joint
CC       contractures resulting from reduced or absent fetal movements. AMC1 is
CC       an autosomal recessive severe form with onset in utero. Most affected
CC       individuals die in utero. Those who survive have generalized
CC       contractures and hypotonia. The disorder is caused by a neurogenic
CC       defect and poor or absent myelin formation around peripheral nerves
CC       rather than by a muscular defect. {ECO:0000269|PubMed:28318499}.
CC       Note=The disease is caused by variants affecting the gene represented
CC       in this entry.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; AF467954; AAM49552.1; -; mRNA.
DR   EMBL; AJ487959; CAD32306.1; -; mRNA.
DR   EMBL; AJ487519; CAD31787.1; -; mRNA.
DR   EMBL; AY358121; AAQ88488.1; -; mRNA.
DR   EMBL; BC087848; AAH87848.1; -; mRNA.
DR   EMBL; BC136694; AAI36695.1; -; mRNA.
DR   EMBL; BC136697; AAI36698.1; -; mRNA.
DR   CCDS; CCDS12444.1; -. [Q8N135-1]
DR   RefSeq; NP_644813.1; NM_139284.2. [Q8N135-1]
DR   AlphaFoldDB; Q8N135; -.
DR   SMR; Q8N135; -.
DR   BioGRID; 127855; 1.
DR   STRING; 9606.ENSP00000312273; -.
DR   GlyGen; Q8N135; 2 sites, 2 O-linked glycans (1 site).
DR   iPTMnet; Q8N135; -.
DR   PhosphoSitePlus; Q8N135; -.
DR   BioMuta; LGI4; -.
DR   DMDM; 32469741; -.
DR   MassIVE; Q8N135; -.
DR   PaxDb; Q8N135; -.
DR   PeptideAtlas; Q8N135; -.
DR   PRIDE; Q8N135; -.
DR   ProteomicsDB; 71534; -. [Q8N135-1]
DR   ProteomicsDB; 71535; -. [Q8N135-2]
DR   Antibodypedia; 29282; 165 antibodies from 25 providers.
DR   DNASU; 163175; -.
DR   Ensembl; ENST00000310123.8; ENSP00000312273.3; ENSG00000153902.14. [Q8N135-1]
DR   Ensembl; ENST00000591633.2; ENSP00000467784.1; ENSG00000153902.14. [Q8N135-2]
DR   GeneID; 163175; -.
DR   KEGG; hsa:163175; -.
DR   MANE-Select; ENST00000310123.8; ENSP00000312273.3; NM_139284.3; NP_644813.1.
DR   UCSC; uc002nxx.3; human. [Q8N135-1]
DR   CTD; 163175; -.
DR   DisGeNET; 163175; -.
DR   GeneCards; LGI4; -.
DR   HGNC; HGNC:18712; LGI4.
DR   HPA; ENSG00000153902; Low tissue specificity.
DR   MalaCards; LGI4; -.
DR   MIM; 608303; gene.
DR   MIM; 617468; phenotype.
DR   neXtProt; NX_Q8N135; -.
DR   OpenTargets; ENSG00000153902; -.
DR   Orphanet; 2680; Hypomyelination neuropathy-arthrogryposis syndrome.
DR   PharmGKB; PA38656; -.
DR   VEuPathDB; HostDB:ENSG00000153902; -.
DR   eggNOG; ENOG502SHYJ; Eukaryota.
DR   GeneTree; ENSGT00940000162018; -.
DR   HOGENOM; CLU_036403_0_0_1; -.
DR   InParanoid; Q8N135; -.
DR   OMA; GKCPPRC; -.
DR   PhylomeDB; Q8N135; -.
DR   TreeFam; TF333155; -.
DR   PathwayCommons; Q8N135; -.
DR   Reactome; R-HSA-5682910; LGI-ADAM interactions.
DR   BioGRID-ORCS; 163175; 12 hits in 1062 CRISPR screens.
DR   ChiTaRS; LGI4; human.
DR   GenomeRNAi; 163175; -.
DR   Pharos; Q8N135; Tbio.
DR   PRO; PR:Q8N135; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q8N135; protein.
DR   Bgee; ENSG00000153902; Expressed in tibial nerve and 147 other tissues.
DR   ExpressionAtlas; Q8N135; baseline and differential.
DR   Genevisible; Q8N135; HS.
DR   GO; GO:0005576; C:extracellular region; TAS:Reactome.
DR   GO; GO:0005615; C:extracellular space; IBA:GO_Central.
DR   GO; GO:0008344; P:adult locomotory behavior; IEA:Ensembl.
DR   GO; GO:0014009; P:glial cell proliferation; IEA:Ensembl.
DR   GO; GO:0022011; P:myelination in peripheral nervous system; IBA:GO_Central.
DR   GO; GO:0042551; P:neuron maturation; IBA:GO_Central.
DR   GO; GO:0031641; P:regulation of myelination; IMP:UniProtKB.
DR   Gene3D; 3.80.10.10; -; 1.
DR   InterPro; IPR000483; Cys-rich_flank_reg_C.
DR   InterPro; IPR009039; EAR.
DR   InterPro; IPR005492; EPTP.
DR   InterPro; IPR001611; Leu-rich_rpt.
DR   InterPro; IPR003591; Leu-rich_rpt_typical-subtyp.
DR   InterPro; IPR032675; LRR_dom_sf.
DR   Pfam; PF03736; EPTP; 3.
DR   Pfam; PF13855; LRR_8; 1.
DR   SMART; SM00369; LRR_TYP; 3.
DR   SMART; SM00082; LRRCT; 1.
DR   PROSITE; PS50912; EAR; 7.
DR   PROSITE; PS51450; LRR; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; Disease variant; Glycoprotein; Leucine-rich repeat;
KW   Reference proteome; Repeat; Secreted; Signal.
FT   SIGNAL          1..19
FT                   /evidence="ECO:0000255"
FT   CHAIN           20..537
FT                   /note="Leucine-rich repeat LGI family member 4"
FT                   /id="PRO_0000017712"
FT   REPEAT          53..74
FT                   /note="LRR 1"
FT   REPEAT          77..98
FT                   /note="LRR 2"
FT   REPEAT          101..122
FT                   /note="LRR 3"
FT   REPEAT          125..146
FT                   /note="LRR 4"
FT   DOMAIN          158..208
FT                   /note="LRRCT"
FT   REPEAT          210..252
FT                   /note="EAR 1"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          256..298
FT                   /note="EAR 2"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          302..349
FT                   /note="EAR 3"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          351..394
FT                   /note="EAR 4"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          396..439
FT                   /note="EAR 5"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          441..483
FT                   /note="EAR 6"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   REPEAT          487..532
FT                   /note="EAR 7"
FT                   /evidence="ECO:0000255|PROSITE-ProRule:PRU00075"
FT   CARBOHYD        177
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         210..261
FT                   /note="ELSWFQTVGESALSVEPFSYQGEPHIVLAQPFAGRCLILSWDYSLQRFRPEE
FT                   -> GGGLSRWGGRREIWGKGCQGQEARLTPCPAISRSGKTLSKQHCLPEPQFSHL (in
FT                   isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009230"
FT   VAR_SEQ         262..537
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:12975309,
FT                   ECO:0000303|PubMed:15489334"
FT                   /id="VSP_009231"
FT   VARIANT         258
FT                   /note="R -> P (in AMC1; dbSNP:rs755500591)"
FT                   /evidence="ECO:0000269|PubMed:28318499"
FT                   /id="VAR_080055"
FT   VARIANT         288..537
FT                   /note="Missing (in AMC1)"
FT                   /evidence="ECO:0000269|PubMed:28318499"
FT                   /id="VAR_080056"
FT   VARIANT         434
FT                   /note="V -> D (in AMC1; dbSNP:rs1064797094)"
FT                   /evidence="ECO:0000269|PubMed:28318499"
FT                   /id="VAR_080057"
SQ   SEQUENCE   537 AA;  59141 MW;  47B920C809679926 CRC64;
     MGGAGILLLL LAGAGVVVAW RPPKGKCPLR CSCSKDSALC EGSPDLPVSF SPTLLSLSLV
     RTGVTQLKAG SFLRIPSLHL LLFTSNSFSV IEDDAFAGLS HLQYLFIEDN EIGSISKNAL
     RGLRSLTHLS LANNHLETLP RFLFRGLDTL THVDLRGNPF QCDCRVLWLL QWMPTVNASV
     GTGACAGPAS LSHMQLHHLD PKTFKCRAIE LSWFQTVGES ALSVEPFSYQ GEPHIVLAQP
     FAGRCLILSW DYSLQRFRPE EELPAASVVS CKPLVLGPSL FVLAARLWGG SQLWARPSPG
     LRLAPTQTLA PRRLLRPNDA ELLWLEGQPC FVVADASKAG STTLLCRDGP GFYPHQSLHA
     WHRDTDAEAL ELDGRPHLLL ASASQRPVLF HWTGGRFERR TDIPEAEDVY ATRHFQAGGD
     VFLCLTRYIG DSMVMRWDGS MFRLLQQLPS RGAHVFQPLL IARDQLAILG SDFAFSQVLR
     LEPDKGLLEP LQELGPPALV APRAFAHITM AGRRFLFAAC FKGPTQIYQH HEIDLSA
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024